immatics biotechnologies GmbH (IMTXW) — Net Asset Momentum
immatics biotechnologies GmbH (IMTXW) recorded a net asset momentum of 155.4% as of December 2024, with net assets of $574.84 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See IMTXW days of operational coverage to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
immatics biotechnologies GmbH Net Asset Momentum (2018–2024)
This chart tracks immatics biotechnologies GmbH's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +155.4%, with net assets of $574.84 Million USD as of December 2024. Read IMTXW total debt and obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for immatics biotechnologies GmbH (2018–2024)
The table below shows the complete annual net asset history for immatics biotechnologies GmbH from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see immatics biotechnologies GmbH stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $574.84 Million | $696.15 Million | $121.30 Million | ▲ +155.4% |
| 2023 | $225.08 Million | $509.96 Million | $284.88 Million | ▲ +5.6% |
| 2022 | $213.16 Million | $407.82 Million | $194.66 Million | ▲ +785.9% |
| 2021 | $24.06 Million | $174.65 Million | $150.58 Million | ▼ -76.9% |
| 2020 | $104.26 Million | $254.65 Million | $150.39 Million | ▲ +355.3% |
| 2019 | $-40.84 Million | $134.28 Million | $175.11 Million | ▼ -345.3% |
| 2018 | $-9.17 Million | $61.32 Million | $70.49 Million | — |